Reduction in cholesterol absorption in Caco-2 cells through the down-regulation of Niemann-Pick C1-like 1 by the putative probiotic strains Lactobacillus rhamnosus BFE5264 and Lactobacillus plantarum NR74 from fermented foods

International Journal of Food Sciences and Nutrition

Volumn 64, Issue 1, 2013, Pages 44-52

  Yoon, Hong Sup ^a   Ju, Jae Hyun ^a,b   Kim, Han Nah ^a   Park, Hyun Joon ^a   Ji, Yosep ^a   Lee, Ji Eun ^a   Shin, Hyeun Kil ^a   Do, Myoung Sool ^a   Holzapfel, Wilhelm ^a  

^a Handong University   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

Caco 2 cells; Cholesterol; Hypercholesterolaemia; Liver X receptor; Probiotic lactobacilli

Indexed keywords

CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; MEMBRANE PROTEIN; MESSENGER RNA; NPC1L1 PROTEIN, HUMAN; PROBIOTIC AGENT;

ARTICLE; CELL STRAIN CACO 2; CELL WALL; DIET; DOWN REGULATION; FERMENTATION; FOOD CONTROL; HEAT; HUMAN; HYPERCHOLESTEROLEMIA; INTESTINE ABSORPTION; INTESTINE CELL; ISOLATION AND PURIFICATION; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; METABOLISM;

ANTICHOLESTEREMIC AGENTS; CACO-2 CELLS; CELL WALL; CHOLESTEROL; DIET; DOWN-REGULATION; ENTEROCYTES; FERMENTATION; FOOD MICROBIOLOGY; HOT TEMPERATURE; HUMANS; HYPERCHOLESTEROLEMIA; INTESTINAL ABSORPTION; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; MEMBRANE PROTEINS; PROBIOTICS; RNA, MESSENGER;

BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS;

EID: 84872023897     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2012.706598     Document Type: Article

References (60)

1. Agerbeck M, Gerdes LU, Richelsen B. 1995. Hypocholesterolaemic effect of a new fermented milk product in healthy middle aged men. Eur J Clin Nutr 49:346-352.
2. Agerholm-Larsen L, Bell ML, Grunwald GK, Astrup A. 2000. The effect of a probiotic milk product on plasma cholesterol: a meta2-analysis of short-term intervention studies. Eur J Clin Nutr 54:856-860.
3. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. 2004. Probiotics for treating infectious diarrhoea (Cochrane Review) The Cochrane Library Issue 3, 2004. Chichester: Wiley.
4. Altmann SW, Davis HR, Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, et al. 2004. Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science 303:1201-1204.
5. Anderson JW, Gilliland SE. 1999. Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr 18:43-50.
6. Beganović J, Frece J, Kos B, Pavunc AL, Habjanič K, Sušković J. 2011. Functionality of the S-layer protein from the probiotic strain Lactobacillus helveticus M92. Antonie Van Leeuw 100: 43-53.
7. Bertolami MC, Faludi AA, Batlouni M. 1999. Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia. Eur J Clin Nutr 53:97-101.
8. Betters JL, Yu L. 2010. NPC1L1 and cholesterol transport. FEBS Lett 584:2740-2747.
9. Bradley MN, Hong C, Chen M, Joseph SB, Wilpitz DC, Wang X, et al. 2007. Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE. J Clin Invest 117:2337-2346.
10. Brown JM, Yu L. 2009. Opposing gatekeepers of apical sterol transport: Niemann-Pick C1-Like 1 (NPC1L1) and ATP-Binding Cassette Transporters G5 and G8 (ABCG5/ABCG8). Immunol Endocrine Metabol Agents-Med Chem 9:18-29.
11. Caselli M, Vaira G, Calo G, Papini F, Holton J, Vaira D. 2011. Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics. Adv Nutr 2: 372-376.
12. Davis HR, Jr, Zhu LJ, Hoos LM, Tetzloff G, Maguire M, Liu J, et al. 2004. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem 279: 33586-33592.
13. Davis HR, Hoos LM, Tetzloff G, Maguire M, Zhu L, Graziano MP, Altmann SW. 2007. Deficiency of Niemann-Pick C1 Like 1 prevents atherosclerosis in ApoE 2/2 Mice. Arterioscler Thromb Vasc Biol 27:841-849.
14. De Smet I, De Boever P, Verstraete W. 1998. Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity. Br J Nutr 79:185-194.
15. Do MS, Hyun CK, Choi BH, Kim YH, Park JW, Lee SY. 2006. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte. Exp Mol Med 38: 599-605.
16. Du Toit M, Franz CMAP, Dicks LMT, Schillinger U, Haberer P, Warlies B, et al. 1998. Characterisation and selection of probiotic lactobacilli for a preliminary minipig feeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture content. Int J Food Microbiol 40:93-104.
17. Duval C, Touche V, Tailleux A, Fruchart JC, Fievet C, Clavey V, et al. 2006. Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine. Biochem Biophys Res Commun 340:1259-1263.
18. Engle MJ, Goetz GS, Alpers DH. 1998. Caco-2 cells express a combination of colonocyte and enterocyte. Phenotypes J Cell Physiol 174:362-369.
19. Field FJ, Watt K, Mathur SN. 2007. Ezetimibe interferes with cholesterol trafficking from the plasma membrane to the endoplasmic reticulum in CaCo-2 cells. J Lipid Res 48: 1735-1745.
20. Franz CMAP, Cho GY, Holzapfel WH. 2010. Probiotics: taxonomy and technological features. In: Shah NP, da Cruz AG, de Assis Fonseca Faria J, editors. Probiotic and prebiotic foods: technology, stability and benefits to human health. Chapter 1 Hauppauge, NY: Nova Science Publishers.
21. Fukushima M, Nakano M. 1996. Effects of a mixture of organisms, Lactobacillus acidophilus or Streptococcus faecalis on cholesterol metabolism in rats fed on a fat-and cholesterol-enriched diet. Br J Nutr 76:857-867.
22. Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, et al. 2005. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA 10:8132-8137.
23. Gylling H, Miettinen TA. 1995. The effect of cholesterol absorption inhibition on low density lipoprotein cholesterol level. Atherosclerosis 117:305-308.
24. Harrison VC, Peat G. 1975. Serum cholesterol and bowel flora in the newborn. Am J Clin Nutr 28:1351-1355.
25. Huang Y, Zheng Y. 2010. The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann-Pick C1-like 1 in Caco-2 cells. Br J Nutr 103: 473-478.
26. Huang Y, Wang J, Cheng Y, Zheng Y. 2010. The hypocholester-olaemic effects of Lactobacillus acidophilus American type culture collection 4356 in rats are mediated by the down-regulation of Niemann-Pick C1-Like 1. Br J Nutr 104:807-812.
27. Jeun J, Kim S, Cho S-Y, Jun H-J, Park H-J, Seo J-G, et al. 2010. Hypocholesterolemic effects of Lactobacillus plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice. Nutrition 26:321-330.
28. Jiao R, Guan L, Yang N, Peng C, Liang Y, Ma KY, et al. 2010. Frequent cholesterol intake up-regulates intestinal NPC1L1, ACAT2, and MTP. J Agric Food Chem 58:5851-5857.
29. Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA, Chen M, Noh G, Goodman J, Hagger GN, Tran J, Tippin TK, Wang X, Lusis AJ, Hsueh WA, Law RE, Collins JL, Willson TM, Tontonoz P. 2002. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA 99:7604-7609.
30. Kim JY, Lee SK, Hachimura S, Kaminogawa S, Lee HJ. 2003. In vitro immunopotentiating activity of cellular components of Lactococcus lactis ssp. lactis. J Microbiol Biotechnol 13: 202-206.
31. Lebeer S, Vanderleyden J, De Keersmaecker SCJ. 2008. Genes and molecules of Lactobacilli supporting probiotic action. Microbiol Mol Biol Rev 72:728-764.
32. Lebeer S, Vanderleyden J, De Keersmaecker SCJ. 2010. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nature Rev Microbiol 8: 171-184.
33. Lee H-J, Yoon H-S, Ji Y, Kim H, Park H-J, Lee J, et al. 2011. Functional properties of Lactobacillus strains isolated from kimchi. Int J Food Microbiol 145:155-161.
34. Liong MT, Shah NP. 2005. Acid and bile tolerance and cholesterol removal ability of Lactobacilli strains. J Dairy Sci 88:55-66.
35. Liong MT, Shah NP. 2006. Effects of a Lactobacillus casei synbiotic on serum lipoprotein, intestinal microflora, and organic acids in rats. J Dairy Sci 89:1390-1399.
36. Lo Sasso G, Murzilli S, Salvatore L, D'Errico I, Petruzzelli M, Conca P, et al. 2011. Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab 12:187-193.
37. Lubbadeh W, Haddadin MSY, Al-Tamimi MA, Robinson RK. 1999. Effect on the cholesterol content of fresh lamb of supplementing the feed of Awassi Ewes and lambs with Lactobacillus acidophilus. Meat Sci 52:381-385.
38. Lye HS, Rusul G, Liong MT. 2010. Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol. J Dairy Sci 93:1383-1392.
39. Mann GV, Spoerry A. 1974. Studies of a surfactant and cholesteremia in the Maasai. Am J Clin Nutr 27:464-469.
40. Mathara JM, Schillinger U, Guigas C, Franz CMAP, Kutima PM, Mbugua S, et al. 2008. Functional characteristics of Lactobacillus spp. from traditional Maasai fermented milk products in Kenya. Int J Food Microbiol 126:57-64.
41. Miura S, Saku K. 2008. Ezetimibe, a selective inhibitor of the transport of cholesterol. Intern Med 47:1165-1170.
42. Nguyen TDT, Kang JH, Lee MS. 2007. Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects. Int J Food Microbiol 113: 358-361.
43. Ooi LG, Liong MT. 2010. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci 11:2499-2522.
44. Park KY, Rhee SH. 2005. Functional foods from fermented vegetable products: kimchi (Korean fermented vegetables) and functionality. In: Shi J, Ho CT, Shahidi F, editors. Asian functional food. Boca Raton, FL: CRC Press. p 341-380.
45. Perdigon G, Alvarez S, Rachid M, Aguero G, Gobbato N. 1995. Immune system stimulation by probiotics. J Dairy Sci 78: 1597-1606.
46. Poustie VJ, Rutherford P. 2001. Dietary treatment for familial hypercholesterolaemia Cochrane database of systematic reviews 2001, Issue 2. Art. No.: CD001918. DOI: 10.1002/14651858.CD001918.
47. Repa JJ, Li H, Frank-Cannon TC, Valasek MA, Turley SD, Tansey MG, Dietschy JM. 2007. Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse. J Neurol Sci 27: 14470-14480.
48. Richelsen B, Kristensen K, Pedersen SB. 1995. Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins-a placebo-controlled and double blind study. Eur J Clin Nutr 50:811-815.
49. Ringseis R, Wen G, Saal D, Eder K. 2008. Conjugated linoleic acid isomers reduce cholesterol accumulation in acetylated LDL-induced mouse RAW264.7 macrophage-derived foam cells. Lipids 43:913-923.
50. Sanders ME. 2000. Considerations for use of probiotic bacteria to modulate human health. J Nutr 130(2S Suppl):384S-390S.
51. Sané AT, Sinnett D, Delvin E, Bendayan M, Marcil V, Menard D, et al. 2006. Localization and role of NPC1L1 in cholesterol absorption in human intestine. J Lipid Res 47(10):2112-2120.
52. Sudhop T, Lütjohann D, von Bergmann K. 2008. Sterol transporters: targets of natural sterols and new lipid lowering drugs. Pharmacol Therapeut 105:333-341.
53. Tanaka HK, Doesburg T, Iwasaki I, Mierau I. 1999. Screening of lactic acid bacteria for bile salt hydrolase activity. J Dairy Sci 82: 1530-1535.
54. Temel RE, Tang W, Ma Y, Rudel LL, Willingham MC, Ioannou YA, et al. 2007. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentrations and is a target of ezetimibe. J Clin Invest 117:1968-1978.
55. Temel RE, Sawyer JK, Yu L, Lord C, Degirolamo C, McDaniel A, et al. 2010. Biliary sterol secretion is not required for macrophage reverse cholesterol transport. Cell Metab 12:96-102.
56. Tontonoz P. 2011. Transcriptional and posttranscriptional control of cholesterol homeostasis by liver X receptors Cold Spring Harbor Symp Quant Biol, Published in Advance August 22, 2011, doi: 10.1101/sqb.2011.76.010702.
57. Yasuda T, Grillot D, Billheimer JT, Briand F, Delerive P, Huet S, Rader DJ. 2010. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol 30:781-786.
58. Yoon HS, Ju JH, Kim H, Lee J, Park HJ, Ji Y, et al. 2011. Lactobacillus rhamnosus BFE 5264 and Lactobacillus plantarum NR74 promote cholesterol excretion through the up-regulation of ABCG5/8 in Caco-2 cells. Probiotics Antimicrob Proteins 3: 194-203.
59. Zelcer N, Tontonoz P. 2006. Liver X receptor as integrators of metabolic and inflammatory signaling. J Clin Invest 116: 607-614.
60. Zhang Y, Zhang X, Chen L, Wu J, Lu WJ, Hwang MT, et al. 2006. Liver X receptor (LXR) agonist TO901317 upregulates SCD1 expression in renal proximal straight tubule. Am J Physiol Renal Physiol 290:F1065-F1073.